Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03557008 · ClinicalTrials.gov registry record · Phase 4
Responses to Rabies Vaccine in Adults With or Without Antibiotics
A Phase 4 study of Rabies Human, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 37
- Enrollment target
- 2
- Study locations
NCT03557008 is a Phase 4 study of Rabies Human that has completed, run by Emory University. The registered enrollment target is 37 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT03557008, a Phase 4 study of Rabies Human, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 37 participants
- Enrollment target
- 2
- Study locations
Study Summary
The use of antibiotics changes micro-organisms in the intestines which may impact the body's vaccine immune response and alter the effectiveness of the rabies vaccine. There will be two randomized groups (1:1 randomization). Group A will start taking an antibiotic regimen by mouth 3 days prior to vaccination and continue taking antibiotics the day of rabies vaccination and one day after vaccination for a total of 5 days. Group B will only receive the rabies vaccination and will not take any antibiotics. The dosage of each antibiotic is taken from their respective package inserts and does not exceed the maximum dose allowed for each antibiotic. The purpose of the study is to look at immune response after rabies vaccination with or without the use of antibiotics from day of vaccination to 28 days post vaccination in both groups.
Conditions Studied
Interventions
- DRUG Vancomycin
- DRUG Metronidazole
- BIOLOGICAL Rabies Vaccine
- DRUG Neomycin Sulfate
Study Locations (2)
Georgia
- Winship Cancer Institute of Emory University - Atlanta
- The Hope Clinic of the Emory Vaccine Center - Decatur
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2018-07-05 |
| Est. Completion | 2022-06-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03557008
The ClinicalTrials.gov registry entry for NCT03557008 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rabies Human appearing as the primary indexed condition, and to 4 interventions - of which Vancomycin is the first listed.
NCT03557008 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT03557008 about?
NCT03557008 is a clinical study titled "Responses to Rabies Vaccine in Adults With or Without Antibiotics". The use of antibiotics changes micro-organisms in the intestines which may impact the body's vaccine immune response and alter the effectiveness of the rabies vaccine. There will be two randomized groups (1:1 randomization). Group A will start taking an antibiotic regimen by mouth 3 days prior to v...
What is the current status of trial NCT03557008?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 37 participants. The study started on 2018-07-05. Estimated completion is 2022-06-02.
What conditions does trial NCT03557008 study?
This clinical trial studies the following conditions: Rabies Human.
What interventions are being tested in trial NCT03557008?
The interventions under investigation include: Vancomycin (DRUG), Metronidazole (DRUG), Rabies Vaccine (BIOLOGICAL), Neomycin Sulfate (DRUG).
Who is sponsoring clinical trial NCT03557008?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03557008 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.